Literature DB >> 1437241

Demonstration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs.

M Cabral1, J O'Grady, J Alexander.   

Abstract

An ELISA and a lymphocyte proliferation assay were used for the detection of anti-Leishmania antibodies and parasite specific cellular immunity respectively in a preliminary study of canine leishmaniasis in Oporto, Portugal. A high rate of infection was found considering the comparatively small group sampled. Of 34 dogs examined two had anti-leishmanial antibodies but their lymphocytes did not proliferate in the presence of Leishmania infantum. Conversely two dogs demonstrated antigen specific lymphocyte proliferation in the absence of any detectable anti-parasite antibodies. To our knowledge this is the first time that cellular immunity and presumably resistance of dogs to leishmanial infection has been demonstrated. These results suggest that there may be a spectrum of canine leishmaniasis similar to that observed in the human disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1437241     DOI: 10.1111/j.1365-3024.1992.tb00026.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  16 in total

1.  Diagnostic techniques to detect cryptic leishmaniasis in dogs.

Authors:  Laura Iniesta; Salceda Fernández-Barredo; Béatrice Bulle; M Teresa Gómez; Renaud Piarroux; Montserrat Gállego; José M Alunda; Montserrat Portús
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

2.  Compensation for decreased expression of B7 molecules on Leishmania infantum-infected canine macrophages results in restoration of parasite-specific T-cell proliferation and gamma interferon production.

Authors:  E Pinelli; V P Rutten; M Bruysters; P F Moore; E J Ruitenberg
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Multicomponent chimeric antigen for serodiagnosis of canine visceral leishmaniasis.

Authors:  M Soto; J M Requena; L Quijada; C Alonso
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

4.  Evaluation of PCR as a diagnostic mass-screening tool to detect Leishmania (Viannia) spp. in domestic dogs (Canis familiaris).

Authors:  Richard Reithinger; Juan Canales Espinoza; Orin Courtenay; Clive R Davies
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

5.  Asymptomatic canine leishmaniasis in Greater Athens area, Greece.

Authors:  V Sideris; G Papadopoulou; E Dotsika; E Karagouni
Journal:  Eur J Epidemiol       Date:  1999-03       Impact factor: 8.082

6.  A cross-sectional study on canine Leishmania (L.) infantum chagasi infection in Amazonian Brazil ratifies a higher prevalence of specific IgG-antibody response than delayed-type hypersensitivity in symptomatic and asymptomatic dogs.

Authors:  Fernando T Silveira; Liliane A Carneiro; Patrícia K S Ramos; Eugênia J Chagas; Luciana V R Lima; Marliane B Campos; Márcia D Laurenti; Claudia M C Gomes; Carlos E P Corbett
Journal:  Parasitol Res       Date:  2012-06-16       Impact factor: 2.289

7.  Dual role of the Leishmania major ribosomal protein S3a homologue in regulation of T- and B-cell activation.

Authors:  A Cordeiro-Da-Silva; M C Borges; E Guilvard; A Ouaissi
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

8.  Epidemiological implications of the use of various methods for the diagnosis of canine leishmaniasis in dogs with different characteristics and in differing prevalence scenarios.

Authors:  Manuel Morales-Yuste; Francisco Morillas-Márquez; Victoriano Díaz-Sáez; Sergio Barón-López; Carmen Acedo-Sánchez; Joaquina Martín-Sánchez
Journal:  Parasitol Res       Date:  2012-01-10       Impact factor: 2.289

9.  Canine leishmaniasis in Brazil: serological follow-up of a dog population in an endemic area of american visceral leishmaniasis.

Authors:  Alba Valéria Machado da Silva; Adelzon Assis de Paula; Daniela de Pita Pereira; Reginaldo Peçanha Brazil; João Carlos Araujo Carreira
Journal:  J Parasitol Res       Date:  2010-01-13

10.  Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis.

Authors:  J Moreno; J Nieto; S Masina; C Cañavate; I Cruz; C Chicharro; E Carrillo; S Napp; C Reymond; P M Kaye; D F Smith; N Fasel; J Alvar
Journal:  Vaccine       Date:  2007-06-04       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.